首页 › 基金 › Versant Venture Management, LLC › CRSP
Versant Venture Management, LLC 对 CRSP 的持仓历史
CRISPR THERAPEUTICS AG · 医疗保健
Versant Venture Management, LLC 在 Q3 2026 的 13F 申报中披露持有 CRSP(CRISPR THERAPEUTICS AG)148,831 股,市值约 US$8.2M,约占其申报组合的 7.55%,在其申报持仓中市值排名第 6 位。 Versant Venture Management, LLC 最近 13 个申报季度中有 13 个季度披露了 CRSP 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Versant Venture Management, LLC 对 CRSP 的持仓演变
Versant Venture Management, LLC 于 Q3 2023 首次披露 CRSP 持仓:498,558 股(约 US$22.6M)。 该持仓在 Q1 2024 达到峰值 498,558 股,市值约 US$34.0M。 在 13 次申报中,Versant Venture Management, LLC 0 次增持、1 次减持、11 次保持不变。 最近一期申报(Q3 2026)显示持股 148,831 股、市值约 US$8.2M。 持仓曾出现大幅变动:Q3 2025 减持约 70% (随后一个季度股价下跌 19%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 498.56K | $22.63M | 新进 |
| Q4 2023 | 498.56K | $31.21M | 持有 |
| Q1 2024 | 498.56K | $33.98M | 持有 |
| Q2 2024 | 498.56K | $26.93M | 持有 |
| Q3 2024 | 498.56K | $23.42M | 持有 |
| Q4 2024 | 498.56K | $19.62M | 持有 |
| Q1 2025 | 498.56K | $16.97M | 持有 |
| Q2 2025 | 498.56K | $24.25M | 持有 |
| Q3 2025 | 148.83K | $9.65M | 减持 |
| Q4 2025 | 148.83K | $7.80M | 持有 |
| Q1 2026 | 148.83K | $7.08M | 持有 |
| Q2 2026 | 148.83K | $8.12M | 持有 |
| Q3 2026 | 148.83K | $8.23M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CRSP 与 13F 数据
CRSP(CRISPR THERAPEUTICS AG)属于医疗保健行业。我们追踪的基金中还有 30 只申报持有 CRSP,申报仓位最大的包括:方舟投资 (US$556.3M), Orbis Allan Gray Ltd (US$297.2M), GSK plc (US$144.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CRSP 的基金
- 方舟投资 10.06M 股 · $556.34M · Q3 2026
- Orbis Allan Gray Ltd 5.45M 股 · $297.20M · Q2 2026
- GSK plc 2.61M 股 · $144.30M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 2.04M 股 · $111.19M · Q2 2026
- Amova Asset Management Americas, Inc. 1.45M 股 · $80.36M · Q3 2026
- EcoR1 Capital, LLC 1.39M 股 · $75.77M · Q2 2026
- NEA Management Company, LLC 1.06M 股 · $57.73M · Q2 2026
更多关于 Versant Venture Management, LLC
常见问题
How long has Versant Venture Management, LLC held CRSP?
Versant Venture Management, LLC has disclosed CRSP holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Versant Venture Management, LLC's current position in CRSP?
As of Q3 2026, Versant Venture Management, LLC holds 148.83K shares of CRSP (CRISPR THERAPEUTICS AG), valued at $8.23M, representing 7.55% of its reported portfolio and ranking #6.
Has Versant Venture Management, LLC been buying or selling CRSP?
In the latest 13F filing (Q3 2026), Versant Venture Management, LLC held unchanged its position in CRSP. The position peaked in Q1 2024 at 498.56K shares.
Which other funds hold CRSP?
Other major institutional holders of CRSP include 方舟投资, Orbis Allan Gray Ltd, GSK plc, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.